President's Malaria Initiative, 44650-44656 [05-15271]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 70, Number 148 (Wednesday, August 3, 2005)]
[Notices]
[Pages 44650-44656]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15271]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


President's Malaria Initiative

    Announcement Type: New.
    Funding Opportunity Number: AA197.
    Catalog of Federal Domestic Assistance Number: 93.283.
    Key Dates: Application Deadline: September 2, 2005.

I. Funding Opportunity Description

    Authority: This program is authorized under sections 307 and 
317(k)(2) of the Public Health Service Act, [42 U.S.C. sections 242l 
and 247b(k)(2)], as amended.

    Purpose: The purpose of the program is to support malaria 
prevention and control and relevant ancillary activities (e.g., 
baseline evaluation, strategy development, training, monitoring and 
program evaluation) in the countries included in President Bush's 
initiative to fight malaria in Africa.
    On June 30, 2005, the President pledged to increase U.S. Government 
funding of malaria prevention and treatment by more than $1 billion 
over five years. The President made this commitment through the G-8 
process as the U.S. contribution to a larger international effort 
needed to reduce malaria deaths, and called on other donors, 
foundations, private, public, and voluntary organizations to match U.S. 
commitments by providing $1.2 billion annually in additional funding by 
2008.
    The President's commitment will more than triple the current U.S. 
funding of malaria prevention and treatment programs in Africa, and is 
in addition to the $200 million each year the United States spends 
today on malaria prevention, treatment, and research. It will increase 
U.S. funding for malaria to more than $500 million annually. The 
current U.S. Government malaria budget for Fiscal Year (FY) 2005 is 
$213.6 million, and of that amount the operating budget of the U.S. 
Department of Health and Human Services (HHS) provides $102.4 million, 
or nearly half of that amount. The U.S. Government is also currently 
supporting malaria control and prevention through the Global Fund to 
Fight AIDS, Tuberculosis and Malaria, which has so far been the largest 
vehicle for U.S. Government assistance to anti-malaria activities; the 
Global Fund has invested over $1 billion in malaria and prevention 
control activities over two years, roughly one-third underwritten by 
the U.S. contribution to the Global Fund. These additional resources 
will complement those of the Global Fund and the World Bank's malaria 
program.
    The President will launch the initiative first in three countries: 
Angola, Tanzania and Uganda. (Uganda and Tanzania are also countries 
under the President's Emergency Plan for AIDS Relief), and will add 
public-private partnerships in Equatorial Guinea and Zambia in FY 2006. 
Over the next several years, the initiative could expand, with other 
partner involvement, to a maximum of 25

[[Page 44651]]

countries. An inter-agency group selected the first countries according 
to an agreed set of criteria, including significant burden of malaria; 
national policies and practices for malaria control consistent with 
international guidelines; country capacity to achieve large-scale 
impact; other donor involvement; U.S. Government on-ground presence; 
performance in other malaria programs, including the Global Fund; and 
demonstrated political will by national government leadership to mount 
a comprehensive effort to control malaria.
    The goal of the President's initiative is to accomplish the 
following after three years of full implementation:
     Reduce malaria deaths in each of the target countries by 
50 percent;
     Achieve 85 percent coverage of proven malaria prevention, 
control and treatment interventions among high-risk groups, 
particularly children and pregnant women;
     Procure directly drugs and other commodities and provide 
training and technical assistance needed to achieve these objectives.
    Specific interventions will include the following:
     Expanding access to long-lasting insecticide treated bed 
nets and indoor household residual spraying with approved insecticides 
to greatly reduce the transmission of malaria.
     Providing effective treatment of malaria through the 
prompt use of new artemisinin combination therapies, now 
internationally accepted as the treatment of choice against malaria. 
Provision of these drugs will be available through public- and private-
sector outlets in target countries and supported by information and 
education campaigns to improve access and delivery of care.
     Providing effective, internationally agreed priority 
interventions for addressing malaria in pregnancy, such as preventive 
treatment of pregnant women; more than 30 million African women who 
live in malaria-endemic areas become pregnant each year and are at risk 
for malaria infection, which contributes to low birth weight and deaths 
among infants.
    Please see https://www.whitehouse.gov/news/releases/2005/06/
20050630-8.html for more information on the President's announcement. 
This program addresses the ``Healthy People 2010'' focus area of 
Immunization and Infectious Diseases.
    Measurable outcomes of the program will be in alignment with the 
numerical goals of the President's Malaria Initiative and the following 
performance goal for the National Center for Infectious Diseases (NCID) 
within the Centers for Disease Control (CDC) and Prevention of the U.S. 
Department of Health and Human Services (HHS): Protect Americans from 
infectious diseases.
    This announcement is only for non-research activities supported by 
HHS/CDC as part of the President's malaria initiative. If an applicant 
proposes research, HHS/CDC will not review the application. For the 
definition of ``research,'' please see the HHS/CDC Web site at the 
following Internet address: https://www.cdc.gov/od/ads/opspoll1.htm.
    Activities: Awardee activities for this program are as follows:
     The applicants and their partner(s) in the malaria-endemic 
countries must:

--Enhance local capacity for implementing methods that will reduce 
malaria transmission and the morbidity and mortality from malaria 
infection in Angola, Equatorial Guinea, Tanzania, Uganda, or Zambia. 
Applicants, in collaboration with the national governments and non-
governmental partners, including faith-based organizations, must base 
their activities on the assessments made U.S. Government interagency 
teams in each of the targeted countries of the President's Malaria 
Initiative (if available prior to the application due date), and plan 
to implement, in collaboration with a partner organization in the host 
country, the priority malaria prevention activities identified through 
the U.S. Government analysis.

     Priority program areas are listed below, and are examples 
of activities that would be appropriate to propose under this 
announcement. The applicant should not duplicate existing efforts. 
Based on their competitive advantage and proven field experience, 
applicants may propose to undertake activities in one or more of the 
priority program areas in a defined population area that will 
contribute to the accomplishment of the numerical Emergency Plan 
targets outlined above. For each of these activities, the grantee will 
give priority to evidence-based, yet culturally adapted, innovative 
approaches. Details and example activities for each appear in the 
attachments, as posted with this announcement on the HHS/CDC Grants and 
Cooperative Agreements Web site page:

     Public health capacity-building for governments or 
institutions so as to contribute to malaria prevention and control. 
(Attachment 1, as posted with this announcement on the HHS/CDC Grants 
and Cooperative Agreements Web site page).

--Increasing the public's access to effective antimalarial drugs and 
appropriate management of malaria illness to reduce malaria-associated 
mortality or the severity and duration of malaria illness. (Attachment 
2, as posted with this announcement on the HHS/CDC Grants and 
Cooperative Agreements Web site page).
--Reducing exposure to malaria, particularly among young children and 
pregnant women, through the use of proven malaria-control 
interventions, which should include the provision of long-lasting 
insecticide-treated nets and indoor household residual insecticide 
spraying. (Attachment 3, as posted with this announcement on the HHS/
CDC Grants and Cooperative Agreements Web site page).
--Preventing malaria and its adverse consequences during pregnancy. 
(Attachment 4, as posted with this announcement on the HHS/CDC Grants 
and Cooperative Agreements Web site page).

--Linking activities described here with related HIV care and other 
social services, and promoting coordination at all levels, including 
through bodies such as village, district, regional and national malaria 
coordination committees and networks of faith-based organizations.

--Program evaluation, particularly assessment of progress against the 
numerical goals of the President's Malaria Initiative. (Attachments 5 
and 6, as posted with this announcement on the HHS/CDC Grants and 
Cooperative Agreements Web site page).

     Attend and participate in an annual meeting of grantee 
representatives and the in-country management of the President's 
Malaria Initiative to present, discuss, and evaluate program 
activities.

Administration

    The winning applicants must comply with all HHS management 
requirements for meeting participation and progress and financial 
reporting for this cooperative agreement. (See HHS Activities and 
Reporting sections below for details.) The winning applicants must also 
comply with all policy directives established by the interagency 
Malaria Coordinator, housed at the U.S. Agency for International 
Development.
    In a cooperative agreement, HHS staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.

[[Page 44652]]

    HHS Activities for this program are as follows:
     Organize an orientation meeting with the grantees to brief 
them on applicable expectations, regulations and key management 
requirements for the U.S. Government, HHS, and the President's Malaria 
Initiative, as well as report formats and contents. The orientation 
could include meetings with staff from HHS agencies and the staff of 
the interagency Malaria Coordinator.
     Review and approve the process used by the grantees to 
select key personnel and/or post-award subcontractors and/or 
subgrantees to be involved in the activities performed under this 
agreement, as part of the annual review and approval of country plans 
for the President's Malaria Initiative, managed by the interagency 
Malaria Coordinator.
     Provide consultation and assistance with training 
curricula and materials, as necessary and appropriate for in-country 
training programs.
     Provide consultation and assistance on methods for 
treatment of malaria, enhancing local capacity to increase use of 
insecticide-treated bed nets and indoor household residual insecticide 
spraying, and/or prevention of malaria and its adverse consequences 
during pregnancy.
     Provide consultation on program evaluation design.
     Review and approve grantees' annual work plan and detailed 
budget, as part of the annual review and approval of country plans for 
the President's Malaria Initiative, managed by the interagency Malaria 
Coordinator.
     Review and approve grantees' monitoring and evaluation 
plans, including for compliance with the strategic information guidance 
established by the interagency Malaria Coordinator.
     Meet on a monthly basis with grantees to assess monthly 
expenditures in relation to approved work plan, and modify plans as 
necessary.
     Participate in an annual meeting of grantee 
representatives to present, discuss, and evaluate program activities.

II. Award Information

    Type of Award: Cooperative Agreement.
    HHS involvement in this program appears in the Activities Section 
above.
    Fiscal Year Funds: 2005.
    Approximate Current Fiscal Year Funding: $600,000.
    Approximate Total Project Period Funding: $1,800,000 (This amount 
is an estimate, and is subject to availability of funds. This includes 
direct or indirect costs.).
    Approximate Number of Awards: Four.
    Approximate Average Award: $150,000 (This amount is for the first 
12-month budget period, and includes both direct and indirect costs).
    Floor of Individual Award Range: None.
    Ceiling of Individual Award Range: $250,000 (This ceiling is for 
the first 12-month budget period. This is for total costs, which would 
include indirect costs.)
    Anticipated Award Date: September 15, 2005.
    Budget Period Length: 12 months.
    Project Period Length: Three years.
    Throughout the project period, HHS' commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government, through annual review and approval 
of country plans for the President's Malaria Initiative, managed by the 
interagency Malaria Coordinator.

III. Eligibility Information

III.1. Eligible applicants

    Eligible applicants that can apply for this funding opportunity are 
listed below:
     Public, non-profit organizations
     Private, non-profit organizations
     Universities
     Colleges
     Research institutions
     Hospitals
     Community-based organizations
     Faith-based organizations
     Federally recognized Indian tribal governments
     Indian tribal organizations
     State and local governments or their Bona Fide Agents 
(this includes the District of Columbia, the Commonwealth of Puerto 
Rico, the Virgin Islands, the Commonwealth of the Northern Marianna 
Islands, American Samoa, Guam, the Federated States of Micronesia, the 
Republic of the Marshall Islands, and the Republic of Palau)
     Political subdivisions of States (in consultation with 
States)
    A Bona Fide Agent is an agency/organization identified by a State 
as eligible to submit an application under the State eligibility in 
lieu of a State application. If applying as a bona fide agent of a 
State or local government, an applicant must provide a letter of 
endorsement from the State or local government concerned as 
documentation of its status as bona fide agent. Please place this 
documentation behind the first page of the application form.
    While both U.S.-based and organizations indigenous to Angola, 
Equatorial Guinea, Tanzania, Uganda, or Zambia are eligible to apply, 
we will give preference to well-established organizations indigenous to 
those countries mentioned above, legally incorporated in those 
countries, that have well-developed management and financial control 
systems and established malaria activities that reach to rural areas of 
those countries.
    Preference will also go to applicants with demonstrated experience 
in working with their identified indigenous country partner(s) on 
malaria prevention and control activities.

III.2. Cost-Sharing or Matching

    Matching funds are not required for this program. Although matching 
funds are not required, preference will go to organizations that can 
leverage additional funds to contribute to achieving the numerical 
goals of the President's Malaria Initiative.

III.3. Other

    If applicants request funding greater than the ceiling of the award 
range, HHS/CDC will consider the application non-responsive, and it 
will not enter into the review process. HHS/CDC will notify the 
applicant that the application did not meet the submission 
requirements.
    Special Requirements: If the application is incomplete or non-
responsive to the requirements listed in this section, it will not 
enter into the review process. We will notify the applicant that the 
application did not meet submission requirements.
     We will consider late applications non-responsive. See 
section ``IV.3. Submission Dates and Times'' for more information on 
deadlines.
     This program is not designed or intended to support 
research, therefore this cooperative agreement will not support any 
research.
     Note: Title 2 of the United States Code section 1611 
states that an organization described in section 501(c)(4) of the 
Internal Revenue Code that engages in lobbying activities is not 
eligible to receive Federal funds that constitute an award, grant, or 
loan.
     Applicants must show an established relationship with 
indigenous partner organization(s) in the country/countries they 
propose for their project by submitting a letter, on the partner's (or 
partners') letterhead, of

[[Page 44653]]

support that shows an established relationship with indigenous partner 
organization(s) in the country/countries the applicant proposes for the 
project.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161-1.
    Electronic Submission: HHS/CDC strongly encourages applicants to 
submit the application electronically by using the forms and 
instructions posted for this announcement on https://www.Grants.gov, the 
official Federal agency-wide E-grant Web site. Only applicants who 
apply on-line are permitted to forego paper copy submission of all 
application forms.
    Paper Submission: Application forms and instructions are available 
on the HHS/CDC Web site, at the following Internet address: https://
www.cdc.gov/od/pgo/forminfo.htm.
    If access to the Internet is not available, or if there is 
difficulty accessing the forms on-line, contact the HHS/CDC Procurement 
and Grants Office Technical Information Management Section (PGO-TIM) 
staff at 770-488-2700, and we can mail the application forms to you.

IV.2. Content and Form of Submission

    Application: Applicants must submit a project narrative the 
application forms, in the following format:
     Maximum number of pages: 25. If your narrative exceeds the 
page limit, we will only review the pages that are within the page 
limit.
     Font size: 12-point, unreduced
     Single-spaced
     Paper size: 8.5 by 11 inches
     Page margin size: One inch
     All pages of the application numbered sequentially from 
page 1 (Application Face Page) to the end of the application, including 
charts, figures, tables, and appendices.
     Printed only on one side of page
     Held together only by rubber bands or metal clips; not 
bound in any other way

    The narrative should address activities the applicant proposes to 
conduct over the entire project period, and must include the following 
items in the order listed:
     Background and Need
     Objectives
     Plan
     Methods
     Performance Methods
     Timeline
     Staff
     Budget Justification (the budget justification will be 
counted in the stated page limit)
     Evidence that the applicant has notified the appropriate 
agency in the government of the partner country/countries of the 
application
     Applicants must show an established relationship with 
partner organization(s) in the country they propose for their project. 
Applicants must include after the face page of the application a letter 
with the indigenous partner's (partners') letterhead that provides a 
brief description of the past and anticipated collaboration between the 
applicant and the partner organization(s) in the host country/countries 
must be included. Applicants must also include evidence (e.g. a letter) 
that they have notified the appropriate agency or Ministry of Health 
(MOH) in the partner country/countries of their intention to apply.
    Applicants may include additional information included in the 
application appendices. The appendices will not count toward the 
narrative page limit. This additional information includes the 
following:
     Curricula Vitaes
     R[eacute]sum[eacute]s
     Organizational Charts
     Letters of Support
     Country Malaria Plan
    The agency or organization is required to have a Dun and Bradstreet 
Data Universal Numbering System (DUNS) number to apply for a grant or 
cooperative agreement from the Federal government. The DUNS number is a 
nine-digit identification number, which uniquely identifies business 
entities. Obtaining a DUNS number is easy and there is no charge. To 
obtain a DUNS number, access www.dunandbradstreet.com or call 1-866-
705-5711.
    For more information, see the HHS/CDC Web site at: https://
www.cdc.gov/od/pgo/funding/grantmain.htm. If the application form does 
not have a DUNS number field, please write the DUNS number at the top 
of the first page of the application, and/or include the DUNS number in 
the application cover letter.
    Additional requirements that might require submittal of additional 
documentation with the application are found in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    Application Deadline Date: September 2, 2005.
    Explanation of Deadlines: Applications must be received in the HHS/
CDC Procurement and Grants Office by 4 p.m. Eastern Time on the 
deadline date.
    Applicants may submit applications electronically at 
www.grants.gov. Applications completed on-line through Grants.gov are 
considered formally submitted when the applicant organization's 
Authorizing Official electronically submits the application to https://
www.grants.gov. HHS/CDC will consider electronic applications as having 
met the deadline if the applicant organization's Authorizing Official 
has submitted the application electronically to Grants.gov on or before 
the deadline date and time.
    If applicants submit material electronically through Grants.gov 
(https://www.grants.gov), the application will be electronically time/
date stamped, which will serve as receipt of submission. Applicants 
will receive an e-mail notice of receipt when HHS/CDC receives the 
application.
    If applicants submit material by the United States Postal Service 
or commercial delivery service, the applicant must ensure the carrier 
will be able to guarantee delivery of the application by the closing 
date and time. If HHS/CDC receives the application after closing date 
because of one of the following: (1) Carrier error, when the carrier 
accepted the package with a guarantee for delivery by the closing date 
and time, or (2) significant weather delays or natural disasters, the 
applicant will have the opportunity to submit documentation of the 
carrier's guarantee. If the documentation verifies a carrier problem, 
HHS/CDC will consider the submission as having been received by the 
deadline.
    If applicants submit material in hard copy, HHS/CDC will not notify 
the applicant upon receipt of the submission. If questions arise on the 
receipt of the application, the applicant should first contact the 
carrier. Applicants with further questions should please contact the 
PGO-TIM staff at (770) 488-2700. The applicant should wait two to three 
days after the submission deadline before calling. This will allow time 
for HHS/CDC to process and log submissions.
    This announcement is the definitive guide on application content, 
submission address, and deadline. It supersedes information provided in 
the application instructions. If the submission does not meet the 
deadline above, it will not be eligible for review, and we will discard 
it. We will notify the applicant if the application did not meet the 
submission requirements.

[[Page 44654]]

IV.4. Intergovernmental Review of Applications

    The application is subject to Intergovernmental Review of Federal 
Programs, as governed by Executive Order (EO) 12372. This order sets up 
a system for state and local governmental review of proposed Federal 
assistance applications. Contact the state single point-of-contact 
(SPOC) as early as possible to alert the SPOC to prospective 
applications, and to receive instructions on the state's process. Visit 
the following Web address to get the current SPOC list: https://
www.whitehouse.gov/omb/grants/spoc.html.

IV.5. Funding Restrictions

    Restrictions, which applicants must take into account while writing 
their budgets, are as follows:

     Funds may not support research.
     Reimbursement of pre-award costs is not allowed.
     Grantees may expend funds for reasonable program purposes, 
including personnel, travel, supplies, and services. Grantees may 
purchase equipment if deemed necessary to accomplish program 
objectives; however, grantees must make any purchases through a 
transparent and competitive process, after having requested and 
received prior approval by HHS/CDC officials in writing.
     The costs that are generally allowable in grants to 
domestic organizations are allowable to foreign institutions and 
international organizations, with the following exception: With the 
exception of the American University, Beirut, the Gorgas Memorial 
Institute, and the World Health Organization, indirect costs will not 
be paid (either directly or through sub-award) to organizations located 
outside the territorial limits of the United States or to international 
organizations regardless of their location.
     The applicant may contract with other organizations under 
this program; however, the applicant must perform a substantial portion 
of the activities (including program management and operations, and 
delivery of prevention services for which funds are required.)
     Applicants shall state all requests for funds contained in 
the budget in U.S. dollars. After making an award, HHS/CDC will not 
compensate foreign grantees for currency exchange fluctuations through 
the issuance of supplemental awards.
     You must obtain annual audit of these HHS/CDC funds 
(program-specific audit) by a U.S.-based audit firm with international 
branches and current licensure/authority in-country, and in accordance 
with International Accounting Standards or equivalent standard(s) 
approved in writing by HHS/CDC.
     HHS/CDC can require a fiscal Recipient Capability 
Assessment, prior to or post award, to review the applicant's business 
management and fiscal capabilities regarding the handling of U.S. 
Federal funds.
    If requesting indirect costs in the budget, a copy of the indirect 
cost rate agreement is required. If the indirect cost rate is a 
provisional rate, the agreement should be less than 12 months old.
    Applicants can find guidance for completing the budget on the HHS/
CDC Web site, at the following Internet address: https://www.cdc.gov/od/
pgo/funding/budgetguide.htm.

IV.6. Other Submission Requirements

    Application Submission Address: Electronic Submission: HHS/CDC 
strongly encourages applicants to submit applications electronically at 
https://www.Grants.gov. Applicants can download the application package 
from https://www.Grants.gov. Applicants are able to complete it off-
line, and then upload and submit the application via the Grants.gov Web 
site. We will not accept e-mail submissions. Applicants that have 
technical difficulties in Grants.gov can reach custumer service by E-
mail at https://www.grants.gov/CustomerSupport or by phone at 1-800-518-
4726 (1-800-518-GRANTS). The Customer Support Center is open from 7 
a.m. to 9 p.m., Eastern Time, Monday through Friday.
    HHS/CDC recommends that submittal of the application to Grants.gov 
should be early to resolve any unanticipated difficulties prior to the 
deadline. Applicants may also submit a back-up paper submission of the 
application. We must receive any such paper submission in accordance 
with the requirements for timely submission detailed in Section IV.3. 
of the grant announcement. Applicants must clearly mark the paper 
submission: ``BACK-UP FOR ELECTRONIC SUBMISSION.'' The paper submission 
must conform to all requirements for non-electronic submissions. If 
HHS/CDC receives both electronic and back-up paper submissions by the 
deadline, we will consider the electronic version the official 
submission.
    We strongly recommend applicants submit the grant application by 
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel, 
etc.). If applicants do not have access to Microsoft Office products, 
they may submit a PDF file. Applicants can find directions for creating 
PDF files on the Grants.gov Web site. Use of file formats other than 
Microsoft Office or PDF may make the file unreadable for our staff.

OR

    Paper Submission: Applicants should submit the original and two 
hard copies of the application by mail or express delivery service to: 
Technical Information Management-RFAAA197, CDC Procurement and 
Grants Office, U.S. Department of Health and Human Services, 2920 
Brandywine Road, Atlanta, GA 30341.

V. Application Review Information

V.1. Criteria

    Applicants must provide measures of effectiveness that will 
demonstrate the accomplishment of the various identified objectives of 
the cooperative agreement. Measures of effectiveness must relate to the 
performance goals stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. Applicants must submit these measures of 
effectiveness with the application, and they will be an element of 
evaluation. HHS/CDC will evaluate the application against the following 
criteria:
1. Plan of Operation (45 Points)
    a. Do the key personnel have the ability and program skills to 
develop and carry out the proposed activities, including by undertaking 
those activities in the appropriate local languages?
    b. Is there good evidence to show the applicant and malaria-endemic 
partner(s) have conducted a collaborative review of the priority needs 
for malaria in the malaria-endemic country/countries?
    c. Do the proposed objectives match the priority issues and 
interventions of the President's Malaria Initiative?
    d. Are the proposed methods reasonable? Will they accomplish the 
program goals? Is the proposed plan reasonable? Does it address major 
project components in both the applicant and malaria-endemic country/
countries (i.e., leadership, staffing, administrative coordination, 
planning, and measurement activities)? Does the timetable incorporate 
the major numerical milestones of the President's Malaria Initiative 
and have a coherent plan to meet those targets?
    e. Is the plan consistent with malaria prevention best practices 
and the

[[Page 44655]]

announced priorities of the President's Malaria Initiative?
    f. If the applicant proposes capacity-building for public health 
activities in malaria, do the planned activities relate to capacity 
improvements that will help achieve the numerical goals of the 
President's Malaria Initiative in the partner country/countries?
2. Collaborative Arrangement(s) (25 Points)
    a. Does the collaboration between the applicant and partner 
organization(s) in the partner country/countries reflect an effective 
working relationship? Will the collaboration enable implementation of 
the proposed activities and serve to achieve the numerical goals of the 
President's Malaria Initiative?
    b. Does the collaboration include the organization(s) responsible 
for policy and implementation of malaria prevention and control in the 
target area (e.g., Ministry of Health and/or district office)?
    c. Are there formal letters of support from appropriate groups 
(universities, non-governmental organizations, etc.) within the 
malaria-endemic country that demonstrate the appropriate and necessary 
cooperation to support malaria prevention and control programs?
3. Background and Need (15 Points)
    a. Does the proposal define and provide evidence that malaria in 
the partner malaria-endemic country/countries is well-established as an 
important cause of morbidity and mortality across the country/
countries?
    b. Is it clear what the existing malaria control program is and 
what its prevention and control strategies are?
    c. Does the application clearly describe the existing surveillance, 
monitoring and evaluation methods and capability?
    d. Does the application clearly describe the gaps and priorities in 
malaria prevention and control implementation?
4. Evaluation Plan (15 Points)
    a. Does the application include a reasonable detailed plan for 
monitoring the implementation of the activities and evaluating the 
extent to which the proposed activities strengthen local and national 
capacity for malaria prevention and control?
    b. Does the monitoring and evaluation plan build on existing 
monitoring and evaluation systems in the project area? Will it be able 
to demonstrate progress towards the objectives and numerical targets of 
the President's Malaria Initiative?
5. Budget (Not Scored)
    Is the budget detailed, clear, justified, and does it describe in-
kind or other project support? Is it consistent with the proposed 
program activities and the President's Malaria Initiative?

V.2. Review and Selection Process

    The Procurement and Grants Office (PGO) will review applications 
for completeness, staff, and HHS/CDC/NCID will review them for 
responsiveness. Incomplete applications and applications that are non-
responsive to the eligibility criteria will not advance through the 
review process. We will notify applicants that their application did 
not meet submission requirements.
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above. The objective review panel will be composed of HHS/CDC 
employees outside of the funding division.
    HHS/CDC will provide justification for any decision to fund out of 
rank order.

V.3. Anticipated Announcement and Award Dates

    Anticipated Award Date: September 15, 2005.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Award (NoA) from the 
HHS/CDC Procurement and Grants Office. The NoA shall be the only 
binding, authorizing document between the recipient and HHS. An 
authorized Grants Management Officer will sign the NoA and mail it to 
the recipient fiscal officer identified in the application. 
Unsuccessful applicants will receive notification by mail of the 
results of the application review.

VI.2. Administrative and National Policy Requirements

    Successful applicants must comply with the administrative 
requirements outlined in 45 CFR Part 74 and Part 92 as appropriate. The 
following additional requirements apply to this project:

AR-7 Executive Order 12372
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status
AR-23 States and Faith-Based Organizations

    Applicants may find additional information on these requirements on 
the HHS/CDC web site at the following Internet address: https://
www.cdc.gov/od/pgo/funding/ARs.htm.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: https://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    Applicants must include an additional Certifications form from the 
PHS5161-1 application in the Grants.gov electronic submission only. 
Applicants should refer to https://www.cdc.gov/od/pgo/funding/PHS5161-1-
Certificates.pdf. Once applicants have filled out the form, they should 
attach it to the Grants.gov submission as Other Attachments Form.

VI.3. Reporting Requirements

    The applicant must provide HHS/CDC with an original, plus two hard 
copies of the following reports:
    1. Interim progress report, no less than 90 days before the end of 
the budget period. The progress report will serve as the application 
for continuation, and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Budget.
    e. Measures of Effectiveness, including progress against the 
specific numerical targets of the President's Malaria Initiative.
    f. Additional Requested Information.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final performance reports, no more than 90 days after the end of 
the project period.
    The grantee must mail these reports to the Grants Management 
Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    HHS encourages inquiries concerning this announcement.
    For general questions, please contact the following office: 
Technical Information Management Section, CDC Procurement and Grants 
Office, U.S. Department of Health and Human Services, 2920 Brandywine 
Road, Atlanta, GA 30341, Telephone: 770-488-2700.
    For program technical assistance, please contact the following: 
Christi Murray, Project Officer, National Center

[[Page 44656]]

for Infectious Diseases, Centers for Disease Control and Prevention, 
U.S. Department of Health and Human Services, 4770 Buford Highway, 
Mailstop F-22, Atlanta, GA 300341. Telephone: 770-488-3601. E-mail: 
cxm6@cdc.gov.
    For financial, grants management, or budget assistance, please 
contact the following: Jeff Napier, Grants Management Specialist, CDC 
Procurement and Grants Office, U.S. Department of Health and Human 
Services, 2920 Brandywine Road, Atlanta, GA 30341. Telephone: 770-488-
2614. E-mail: jln1@cdc.gov.

VIII. Other Information

    Other HHS funding opportunity announcements can be found on the 
HHS/CDC web site, Internet address: https://www.cdc.gov (Click on 
``Funding,'' then ``Grants and Cooperative Agreements''), and on the 
HHS Office of Global Health Affairs Web site, Internet address: https://
www.globalhealth.gov (Click on ``What's new,'' then ``Funding 
Opportunities.'').

    Dated: July 28, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention, U.S. Department of Health and Human Services.
[FR Doc. 05-15271 Filed 8-2-05; 8:45 am]
BILLING CODE 4163-18-P